One-Year Results of Long femoropopliteal Lesions Stenting with Fasciotomy Lamina Vastoadductoria

Published:August 31, 2022DOI:


      Fasciotomy can increase the mobility of the superficial femoral artery and decrease the incidence of stent fractures. This study aimed to compare the long-term patency of drug-eluting nitinol stents with and without fasciotomy in patients with prolonged superficial femoral artery occlusions.


      A randomized clinical trial was conducted in 60 (1:1) patients with long femoropopliteal steno-occlusive lesions >200 mm. Patients in group 1 (Zilver) underwent recanalization of femoropopliteal artery occlusion with stenting. In group 2 (ZilverFas), the femoropopliteal occlusion was recanalized with stenting and fasciotomy of Gunter’s canal. The follow-up assessment of the patency took place after 6–12 months.


      Twelve-month primary patency in Zilver and ZilverFas groups was 51% and 80%, respectively (P = 0.02). The freedom from target lesion revascularization in the Zilver and ZilverFas groups was 50% and 76%, respectively (P = 0.04). At 1 year, primary-assisted patency and secondary patency for the ZilverFas and Zilver groups were 83% vs. 62% (P = 0.07) and 86% vs. 65% (P = 0.05), respectively. In the Zilver and ZilverFas groups, the number of stent fractures was 14 and 7, respectively (P = 0.05). The multivariable Cox regression indicated that the stent fracture and diabetes mellitus were independent predictors of restenosis and reocclusion. Fasciotomy reduced the risk of reocclusion and restenosis by 2.94 times.


      Our study has shown that decompressing the stented segment with fasciotomy significantly improves the patency of the femoropopliteal segment and significantly reduces the number and severity of stent fractures.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jens S.
        • Conijn A.
        • Koelemay M.
        • et al.
        SB-EJ of, 2014 U. Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (part 1: above the knee).
        Eur J Vasc Endovasc Surg. 2014; 47: 524-535
        • Mazzaccaro D.
        • Berti F.
        • Antonini L.
        • et al.
        Biomechanical interpretation of observed fatigue fractures of peripheral Nitinol stents in the superficial femoral arteries through in silico modelling.
        Med Hypotheses. 2020; 142: 109771
        • Rits J.
        • van Herwaarden J.A.
        • Jahrome A.K.
        • et al.
        The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings.
        Eur J Vasc Endovasc Surg. 2008; 36: 339-345
        • Rabtsun A.
        • Karpenko A.
        • Zoloev D.G.
        • et al.
        Remote endarterectomy and lamina vastoadductoria dissection improves superficial femoral artery biomechanical behavior during limb flexion.
        Ann Vasc Surg. 2018; 50: 112-118
        • Karpenko A.A.
        • Rabtsun A.A.
        • Popova I.V.
        • et al.
        Intermediate results of the prospective randomized study on the effect of lamina vastoadductoria dissection after superficial femoral artery stenting on the restenosis incidence in TASC-II type C and D lesions.
        Cardiovasc Ther Prev. 2020; 19: 55-62
        • Jaff M.
        • Dake M.
        • Pompa J.
        • et al.
        Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices.
        Catheter Cardiovasc Interv. 2007; 70: 460-462
        • Petrini L.
        • Wu W.
        • Dordoni E.
        • et al.
        Fatigue behavior characterization of nitinol for peripheral stents.
        Funct Mater Lett. 2012; 5: 1250012
        • Dordoni E.
        • Meoli A.
        • Wu W.
        • et al.
        Fatigue behaviour of Nitinol peripheral stents: the role of plaque shape studied with computational structural analyses.
        Med Eng Phys. 2014; 36: 842-849
        • Jadidi M.
        • Razian S.A.
        • Anttila E.
        • et al.
        Comparison of morphometric, structural, mechanical, and physiologic characteristics of human superficial femoral and popliteal arteries.
        Acta Biomater. 2021; 121: 431-443
        • Schlager O.
        • Dick P.
        • Sabeti S.
        • et al.
        Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures.
        J Endovasc Ther. 2005; 12: 676-684
        • Nikanorov A.
        • Smouse H.B.
        • Osman K.
        • et al.
        Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions.
        J Vasc Surg. 2008; 48: 435-440
        • Allie D.E.
        • Hebert C.J.
        • Walker C.M.
        Nitinol Stent Fractures in the SFA the biomechanical forces exerted on the SFA provide a “stiff” challenge to endovascular stenting.
        Endovasc Today. 2004; 7: 22-34
        • Davaine J.-M.
        • Querat J.
        • Kaladji A.
        • et al.
        Treatment of TASC C and D femoropoliteal lesions with paclitaxel eluting stents: 12 month results of the STELLA-PTX registry.
        Eur J Vasc Endovasc Surg. 2015; 50: 631-637
        • Vent P.-A.
        • Kaladji A.
        • Davaine J.-M.
        • et al.
        Bare metal versus paclitaxel eluting stents for long femoropopliteal lesions: prospective cohorts comparison using a propensity-score matched analysis.
        Ann Vasc Surg. 2016; 43: 166-175
        • Yu Kang W.
        • Campia U.
        • Didier R.J.
        • et al.
        A single center experience of zilver PTX for femoro-popliteal lesions A single center experience of zilver PTX for femoro-popliteal lesions.
        Cardiovasc Revasc Med. 2016; 17: 399-403
        • Fujihara M.
        • Utsunomiya M.
        • Higashimori A.
        • et al.
        Outcomes of Zilver PTX stent implantation for the treatment of complex femoropopliteal artery disease.
        Heart Vessels. 2014; 31: 152-157
        • Smouse H.B.
        The biomechanics of stenting in the distal SFA and popliteal artery.
        J Vasc Interv Radiol. 2005; 2: 62-67
        • Burket M.W.
        • Dave R.M.
        • Khan M.A.
        • et al.
        Long-term outcomes after self-expanding nitinol stent implantation for the treatment of lesions in the superficial femoral artery and proximal popliteal artery: 3-year results from the BIOFLEX-I trial.
        Cardiovasc Revasc Med. 2021; 28: 28
        • Koivunen V.
        • Juonala M.
        • Surgery K.M.
        Chronic limb threatening ischemia and diabetes mellitus: the severity of tibial atherosclerosis and outcome after infrapopliteal revascularization.
        Scand J Surg. 2020; 110: 472-482
        • Weissler E.H.
        • Narcisse D.I.
        • Rymer J.A.
        • et al.
        Characteristics and outcomes of patients with diabetes mellitus undergoing peripheral vascular intervention for infrainguinal symptomatic peripheral artery disease.
        Vasc Endovascular Surg. 2021; 55: 124-134
        • Lilja E.
        • Gottsäter A.
        • Miftaraj M.
        • et al.
        The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy-a nationwide propensity score adjusted analysis.
        J Diabetes Complications. 2021; 35: 107675